Published in Cell Rep on December 15, 2011
GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet (2013) 1.91
Common DNA methylation alterations in multiple brain regions in autism. Mol Psychiatry (2013) 1.51
PRRT2 Is a Key Component of the Ca(2+)-Dependent Neurotransmitter Release Machinery. Cell Rep (2016) 1.46
PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology (2012) 1.44
PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures. Neurology (2012) 1.35
PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine. Neurology (2012) 1.32
PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology (2012) 1.28
Genetic and phenotypic heterogeneity in sporadic and familial forms of paroxysmal dyskinesia. J Neurol (2012) 0.98
The genetics of dystonia: new twists in an old tale. Brain (2013) 0.98
PRRT2-related disorders: further PKD and ICCA cases and review of the literature. J Neurol (2013) 0.97
PRRT2 mutations in paroxysmal kinesigenic dyskinesia with infantile convulsions in a Taiwanese cohort. PLoS One (2012) 0.94
PRRT2 Mutant Leads to Dysfunction of Glutamate Signaling. Int J Mol Sci (2015) 0.92
Phenotypic characterisation of canine epileptoid cramping syndrome in the Border terrier. J Small Anim Pract (2013) 0.90
Migraine with aura as the predominant phenotype in a family with a PRRT2 mutation. J Neurol (2012) 0.87
Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients. Chin Med J (Engl) (2016) 0.87
Genomic biomarkers of SUDEP in brain and heart. Epilepsy Behav (2013) 0.87
Next-generation sequencing diagnostics for neurological diseases/disorders: from a clinical perspective. Hum Genet (2013) 0.86
Novel PRRT2 mutation in an African-American family with paroxysmal kinesigenic dyskinesia. BMC Neurol (2012) 0.85
Benign infantile convulsions (IC) and subsequent paroxysmal kinesigenic dyskinesia (PKD) in a patient with 16p11.2 microdeletion syndrome. Neurogenetics (2013) 0.84
Screening of CACNA1A and ATP1A2 genes in hemiplegic migraine: clinical, genetic, and functional studies. Mol Genet Genomic Med (2013) 0.83
The clinical and genetic heterogeneity of paroxysmal dyskinesias. Brain (2015) 0.82
Protein mutated in paroxysmal dyskinesia interacts with the active zone protein RIM and suppresses synaptic vesicle exocytosis. Proc Natl Acad Sci U S A (2015) 0.81
PRRT2 mutations are related to febrile seizures in epileptic patients. Int J Mol Sci (2014) 0.81
Mild paroxysmal kinesigenic dyskinesia caused by PRRT2 missense mutation with reduced penetrance. Neurology (2012) 0.80
A Novel Topology of Proline-rich Transmembrane Protein 2 (PRRT2): HINTS FOR AN INTRACELLULAR FUNCTION AT THE SYNAPSE. J Biol Chem (2016) 0.80
Altered intrinsic brain activity in patients with paroxysmal kinesigenic dyskinesia by PRRT2 mutation: altered brain activity by PRRT2 mutation. Neurol Sci (2013) 0.79
Urine-derived induced pluripotent stem cells as a modeling tool for paroxysmal kinesigenic dyskinesia. Biol Open (2015) 0.78
PRRT2 mutations lead to neuronal dysfunction and neurodevelopmental defects. Oncotarget (2016) 0.78
Lessons learned from gene identification studies in Mendelian epilepsy disorders. Eur J Hum Genet (2015) 0.78
Genetic issues in the diagnosis of dystonias. Front Neurol (2013) 0.77
Phenotypes and PRRT2 mutations in Chinese families with benign familial infantile epilepsy and infantile convulsions with paroxysmal choreoathetosis. BMC Neurol (2013) 0.77
Successful control with carbamazepine of family with paroxysmal kinesigenic dyskinesia of PRRT2 mutation. Biomedicine (Taipei) (2014) 0.77
Primary and secondary dystonic syndromes: an update. Curr Opin Neurol (2013) 0.77
Novel loss-of-function PRRT2 mutation causes paroxysmal kinesigenic dyskinesia in a Han Chinese family. BMC Neurol (2014) 0.77
Epilepsy in 2012: Advances in epilepsy shed light on key questions. Nat Rev Neurol (2013) 0.76
Migraine in the era of precision medicine. Ann Transl Med (2016) 0.76
Heterogeneous pattern of selective pressure for PRRT2 in human populations, but no association with autism spectrum disorders. PLoS One (2014) 0.76
Benign infantile convulsion as a diagnostic clue of paroxysmal kinesigenic dyskinesia: a case series. J Med Case Rep (2014) 0.75
Aberrant transcriptional networks in step-wise neurogenesis of paroxysmal kinesigenic dyskinesia-induced pluripotent stem cells. Oncotarget (2016) 0.75
The PRRT2 knockout mouse recapitulates the neurological diseases associated with PRRT2 mutations. Neurobiol Dis (2016) 0.75
A mutation hot-spot for benign infantile epilepsy. Epilepsy Curr (2013) 0.75
Five cases of paroxysmal kinesigenic dyskinesia by genetic diagnosis. Exp Ther Med (2014) 0.75
Genetic biomarkers in epilepsy. Neurotherapeutics (2014) 0.75
Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder. J Clin Invest (2017) 0.75
Molecular analysis of PRRT2 gene in a case of paroxysmal kinesigenic dyskinesia patient. Ann Indian Acad Neurol (2014) 0.75
The epileptic and nonepileptic spectrum of paroxysmal dyskinesias: Channelopathies, synaptopathies, and transportopathies. Mov Disord (2017) 0.75
The Role of PRRT2 in Synaptic Transmission May Not Be So Benign. Epilepsy Curr (2017) 0.75
Genetics in dystonia: an update. Curr Neurol Neurosci Rep (2013) 0.75
A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer. Oncotarget (2016) 0.75
Intronic PRRT2 mutation generates novel splice acceptor site and causes paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) in a three generation family. BMC Med Genet (2016) 0.75
Paroxysmal hypnogenic dyskinesia is associated with mutations in the PRRT2 gene. Neurol Genet (2016) 0.75
Paroxysmal Dyskinesia in Border Terriers: Clinical, Epidemiological, and Genetic Investigations. J Vet Intern Med (2017) 0.75
Recent advances in epilepsy. J Neurol (2014) 0.75
Re-evaluation of PRRT2 mutations in paroxysmal disorders. J Neurol (2014) 0.75
The genetic relationship between epilepsy and hemiplegic migraine. Neuropsychiatr Dis Treat (2017) 0.75
Integrative genomics viewer. Nat Biotechnol (2011) 42.83
Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science (2009) 21.24
A human protein-protein interaction network: a resource for annotating the proteome. Cell (2005) 18.97
Frequent mutation of BAP1 in metastasizing uveal melanomas. Science (2010) 7.47
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology (2004) 2.70
Dystonia. N Engl J Med (2006) 2.66
Paroxysmal kinesigenic dyskinesia and infantile convulsions: clinical and linkage studies. Neurology (2000) 2.48
Paroxysmal dyskinesias: clinical features and classification. Ann Neurol (1995) 2.21
Vesicular restriction of synaptobrevin suggests a role for calcium in membrane fusion. Nature (2002) 2.11
Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet (1997) 1.79
A locus for paroxysmal kinesigenic dyskinesia maps to human chromosome 16. Neurology (2000) 1.73
GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest (2008) 1.60
Paroxysmal dyskinesias. Mov Disord (2011) 1.53
The SNARE protein SNAP-25 is linked to fast calcium triggering of exocytosis. Proc Natl Acad Sci U S A (2002) 1.46
The monogenic primary dystonias. Brain (2009) 1.42
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain (2008) 1.41
Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1. Am J Hum Genet (1999) 1.39
The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet (2004) 1.29
Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway confers the somatodendritic exocytosis of monoamines. Neuron (2005) 1.21
Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology (2007) 1.19
Linkage of benign familial infantile convulsions to chromosome 16p12-q12 suggests allelism to the infantile convulsions and choreoathetosis syndrome. Am J Hum Genet (2001) 1.19
Genetics of infantile seizures with paroxysmal dyskinesia: the infantile convulsions and choreoathetosis (ICCA) and ICCA-related syndromes. J Med Genet (2008) 1.18
Secondary paroxysmal dyskinesias. Mov Disord (2002) 1.17
Episodic neurological channelopathies. Neuron (2010) 1.16
GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias. Mov Disord (2009) 1.14
Association of infantile convulsions with paroxysmal dyskinesias (ICCA syndrome): confirmation of linkage to human chromosome 16p12-q12 in a Chinese family. Hum Genet (1998) 1.04
Infantile convulsions with paroxysmal dyskinesia (ICCA syndrome) and copy number variation at human chromosome 16p11. PLoS One (2010) 1.04
Infantile convulsions with mild gastroenteritis. Brain Dev (2000) 1.03
Paroxysmal kinesigenic choreoathetosis (PKC): confirmation of linkage to 16p11-q21, but unsuccessful detection of mutations among 157 genes at the PKC-critical region in seven PKC families. J Hum Genet (2007) 1.02
16p11.2-related paroxysmal kinesigenic dyskinesia and dopa-responsive parkinsonism in a child. Neurology (2009) 1.01
Refinement of the chromosome 16 locus for benign familial infantile convulsions. Clin Genet (2005) 0.96
Cloning and sequence analysis of the human SNAP25 cDNA. Gene (1994) 0.96
Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia. J Clin Invest (2012) 0.92
Benign familial infantile convulsions: linkage to chromosome 16p12-q12 in 14 families. Epilepsia (2004) 0.91
Paroxysmal kinesigenic choreoathetosis in hyperthyroidism. Postgrad Med J (1987) 0.90
Localization and mutation detection for paroxysmal kinesigenic choreoathetosis. J Mol Neurosci (2007) 0.90
Mutation and copy number analysis in paroxysmal kinesigenic dyskinesia families. Mov Disord (2011) 0.89
Paroxysmal dyskinesias in patients with HIV infection. Neurology (1999) 0.86
Co-occurrence of infantile epileptic seizures and childhood paroxysmal choreoathetosis in one family: clinical, EEG, and SPECT characterization of episodic events. Mov Disord (2002) 0.83
Paroxysmal kinesigenic dystonic choreoathetosis associated with a thalamic infarct. Mov Disord (1990) 0.82
Topiramate therapy for paroxysmal kinesigenic choreoathetosis. Mov Disord (2005) 0.81
Symptomatic paroxysmal kinesigenic choreoathetosis as primary manifestation of multiple sclerosis. J Neurol (2011) 0.80
Diabetes mellitus presenting as paroxysmal kinesigenic dystonic choreoathetosis. Mov Disord (1995) 0.79
Infantile convulsions and paroxysmal kinesigenic choreoathetosis in a patient with idiopathic hypoparathyroidism. Brain Dev (2000) 0.79
The minimum information about a genome sequence (MIGS) specification. Nat Biotechnol (2008) 31.04
The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res (2005) 29.61
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol (2008) 21.53
Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol (2007) 16.81
Quality control and preprocessing of metagenomic datasets. Bioinformatics (2011) 13.84
Community genomics among stratified microbial assemblages in the ocean's interior. Science (2006) 13.31
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord (2008) 9.52
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet (2009) 9.45
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol (2009) 9.25
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48
A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet (2009) 8.30
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A (2009) 8.25
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol (2010) 7.62
Frequent mutation of BAP1 in metastasizing uveal melanomas. Science (2010) 7.47
Pathogenesis and therapy of psoriasis. Nature (2007) 6.94
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol (2008) 6.76
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci (2010) 6.44
Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science (2007) 6.04
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet (2008) 5.85
A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med (2009) 5.81
Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science (2005) 5.50
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol (2012) 5.18
Phenomenology and classification of dystonia: a consensus update. Mov Disord (2013) 4.98
Lysosomal positioning coordinates cellular nutrient responses. Nat Cell Biol (2011) 4.96
Cadherin 23 and protocadherin 15 interact to form tip-link filaments in sensory hair cells. Nature (2007) 4.87
A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol (2007) 4.63
Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet (2009) 4.61
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol (2009) 4.49
Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature (2005) 4.39
Completing the map of human genetic variation. Nature (2007) 4.38
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
TagCleaner: Identification and removal of tag sequences from genomic and metagenomic datasets. BMC Bioinformatics (2010) 4.32
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA (2006) 4.26
Metagenomic analysis of the microbial community associated with the coral Porites astreoides. Environ Microbiol (2007) 4.21
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat Chem Biol (2008) 4.19
Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ (2013) 4.17
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet (2012) 4.13
Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med (2010) 4.07
Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell (2005) 4.02
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain (2009) 4.01
The development of executive function in early childhood. Monogr Soc Res Child Dev (2003) 4.01
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord (2007) 3.86
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol (2010) 3.84
DICER1 mutations in familial pleuropulmonary blastoma. Science (2009) 3.82
Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet (2012) 3.80
Fast identification and removal of sequence contamination from genomic and metagenomic datasets. PLoS One (2011) 3.74
Cadherin 23 is a component of the tip link in hair-cell stereocilia. Nature (2004) 3.69
The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc Natl Acad Sci U S A (2008) 3.65
Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol (2009) 3.62
Direct genomic selection. Nat Methods (2005) 3.61
Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet (2010) 3.57
DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain (2010) 3.57
SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol (2009) 3.55
A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet (2003) 3.52
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Human tRNA-derived small RNAs in the global regulation of RNA silencing. RNA (2010) 3.40
Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics (2003) 3.39
Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet (2010) 3.39
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet (2003) 3.39
Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet (2010) 3.34
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation (2013) 3.25
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus. Nat Commun (2011) 3.23
Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain (2006) 3.16
Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 3.14
The transcriptional repressor DEC2 regulates sleep length in mammals. Science (2009) 3.12
N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist (2005) 3.11
High-resolution genome-wide mapping of transposon integration in mammals. Mol Cell Biol (2005) 3.10
AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet (2002) 3.09
Polarised asymmetric inheritance of accumulated protein damage in higher eukaryotes. PLoS Biol (2006) 3.06
TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum. Nat Genet (2011) 3.06
Mutations in cadherin 23 affect tip links in zebrafish sensory hair cells. Nature (2004) 3.02
Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. Curr Top Dev Biol (2006) 3.02
A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol (2008) 3.00
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet (2011) 2.97
3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med (2004) 2.96
Viral and microbial community dynamics in four aquatic environments. ISME J (2010) 2.95
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J (2012) 2.94
Experimental and computational assessment of conditionally essential genes in Escherichia coli. J Bacteriol (2006) 2.93
Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet (2002) 2.90
Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology (2002) 2.90
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol (2013) 2.90
Factors predictive of outcome after use of the Ponseti method for the treatment of idiopathic clubfeet. J Bone Joint Surg Am (2004) 2.87
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol (2011) 2.84
Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat Genet (2006) 2.83
Movement disorders in cerebrovascular disease. Lancet Neurol (2013) 2.81
Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet (2010) 2.76
Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord (2006) 2.72
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol (2010) 2.67
Whole proteome analysis of post-translational modifications: applications of mass-spectrometry for proteogenomic annotation. Genome Res (2007) 2.67
Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci (2008) 2.56
Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin Cancer Res (2011) 2.54
Atlas - a data warehouse for integrative bioinformatics. BMC Bioinformatics (2005) 2.51
Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol (2012) 2.50
Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest (2002) 2.48